Smz-Tmp

Verify with FDA CVM →

25 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
25
Total Reports
10
Deaths Reported
4000.0%
Death Rate

Active Ingredients

Smz-Tmp

Administration Routes

UnknownOral

Species Affected

Dog 23
Horse 2

Most Affected Breeds

Retriever - Labrador 4
Retriever - Golden 3
Shepherd Dog - German 3
Bulldog - French 2
Warmblood (unspecified) 2
Mountain Dog - Bernese 1
Boxer (German Boxer) 1
Deutsche Dogge, Great Dane 1
Crossbred Canine/dog 1
Saint Bernard Dog 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 8
Other abnormal test result NOS 7
Weight loss 6
Thrombocytopenia 5
Death 5
Elevated blood urea nitrogen (BUN) 5
Elevated creatinine 5
Elevated total bilirubin 4
Death by euthanasia 4
Hypoalbuminaemia 4
Seizure NOS 3
Hyperphosphataemia 3

Outcome Breakdown

Ongoing
11 (42.3%)
Died
7 (26.9%)
Euthanized
4 (15.4%)
Recovered/Normal
3 (11.5%)
Outcome Unknown
1 (3.8%)

Data Summary

Metric Value
Total adverse event reports 25
Reports involving death 10
Case-fatality rate (reported events) 4000.0%
Distinct species in reports 2
Distinct breeds in reports 16
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Smz-Tmp Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 25 adverse event reports referencing Smz-Tmp, including 10 reports in which the animal died — a 4000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Smz-Tmp. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Smz-Tmp reports are Dog (23 reports), Horse (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (4), Retriever - Golden (3), Shepherd Dog - German (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Smz-Tmp are Lethargy (see also Central nervous system depression in 'Neurological') (8), Other abnormal test result NOS (7), Weight loss (6), Thrombocytopenia (5). Of the 26 reports with a coded outcome, Ongoing is the leading category at 42.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Smz-Tmp.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial